(Q34067968)

English

Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice (English)

1 reference

Europe PubMed Central

30 July 2017

Alzheimer's disease

0 references

author name string

I Cameron

1

1 reference

Europe PubMed Central

30 July 2017

S Curran

2

1 reference

Europe PubMed Central

30 July 2017

P Newton

3

1 reference

Europe PubMed Central

30 July 2017

D Petty

4

1 reference

Europe PubMed Central

30 July 2017

J Wattis

5

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 October 2000

1 reference

Europe PubMed Central

30 July 2017

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

30 July 2017

15

1 reference

Europe PubMed Central

30 July 2017

887-891

1 reference

Europe PubMed Central

30 July 2017

10

1 reference

Europe PubMed Central

30 July 2017

Evaluation of a mental test score for assessment of mental impairment in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination.

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

The Barthel ADL Index: a standard measure of physical disability?

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

Measuring the effects of anti-dementia drugs in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200010%2915%3A10%3C887%3A%3AAID-GPS212%3E3.0.CO%3B2-M

21 January 2018

Identifiers

10.1002/1099-1166(200010)15:10<887::AID-GPS212>3.0.CO;2-M

1 reference

Europe PubMed Central

30 July 2017

release_obtioltu6jdu3i5je7nbhkzrsq

1 reference

https://api.fatcat.wiki/v0/release/obtioltu6jdu3i5je7nbhkzrsq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34067968&oldid=1980037093"